High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation  William Blum, Brian J. Bolwell, Gary Phillips, Sherif S. Farag, Thomas S. Lin, Belinda R. Avalos, Sam L. Penza, Guido Marcucci, John C. Byrd, Matt E. Kalaycio, Ronald M. Sobecks, Brad Pohlman, Stacey Brown, Patrick J. Elder, Edward A. Copelan  Biology of Blood and Marrow Transplantation  Volume 12, Issue 1, Pages 61-67 (January 2006) DOI: 10.1016/j.bbmt.2005.06.004 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Overall survival was dichotomized in 4 different ways. A, Dichotomization is based on a cutoff of circulating blasts <5000/μL. B, Dichotomization is based on <20% bone marrow blasts. C, Dichotomization is based on whether the subject had any circulating blasts. D, Dichotomization is based on whether the patient had ≤2 prior treatments. All 4 Kaplan-Meier survival curves were tested for equality by using a log-rank test. The P values are shown on each graph. Biology of Blood and Marrow Transplantation 2006 12, 61-67DOI: (10.1016/j.bbmt.2005.06.004) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions